VGXI

Happy 4th of July from VGXI! We hope you have a fantastic day celebrating with friends and family.

It’s time once again to peek behind the VGXI curtain and introduce you to another one of our valued employees. Maria Catter is a Downstream Process Technician, and her role is focused on supporting the downstream processing steps for our plasmid DNA products. Maria's love for lab work began in college, and VGXI offered her the perfect opportunity to continue that passion full-time. Here, she enjoys a great work-life balance and gets to apply her academic knowledge in practical, impactful ways—even though she jokes that her family doesn’t quite understand what she does! Maria’s advice for newcomers to the CDMO industry is to learn to be flexible. Especially on the manufacturing side, there are a lot of rules, especially in a regulated environment, but often you need to be adaptable to achieve the end goal. Outside of work, Maria spends time with her husband and two very spoiled fur babies, an Australian Shepherd and a cute-as-a-button Yorkie. She also likes to tap into her creative side and can often be found with a paintbrush in hand. She enjoys painting alone but is always up for a painting session with her friends and colleagues. Maria is always full of laughter and has jokes to tell. We’re lucky to have such a fun and engaging individual to brighten the halls (and labs) at VGXI! Visit our careers page to explore exciting employment opportunities at VGXI. https://lnkd.in/gC_NadXq

A new guidance document from the FDA details a new 'platform technology' process that could accelerate cell and gene therapy approvals. These designations are expected to be especially beneficial for gene therapies that use the same AAV backbone and are developed by the same company. The ability to use prior data from the platforms, such as batch and stability data, manufacturing inspection results, or nonclinical safety data will help expedite therapeutic candidates through the approval process, which is great news for patients! https://lnkd.in/g9fTGBTy

VGXI is delighted to welcome Matt Fisichelli, Business Development Manager, to our team! We are thrilled to have Matt join us and are eager to leverage his expertise to drive our business forward. "I am thrilled to be working at VGXI, where the pioneering advancements in cell and gene therapy are transforming the future of medicines." 

Spotted some friendly neighborhood faces at #BIO2024! 🔬🧬🧪 Laura Lea got to hang out with Rebecca and Justin from Conroe VGXI's marketing team here in San Diego! VGXI's 120,000 sq ft headquarters and manufacturing facility is located in our Deison Technology Park, where they are leaders in Plasmid DNA Manufacturing for gene therapies. We can all agree that biotech belongs in Conroe! #conroetx #biohouston #biotechnology #LifeSciencesIndustry

Hey #BIO2024, Did you know that VGXI has The World’s Largest Capacity for pDNA Manufacturing? Come by Booth #4947 to learn why VGXI is a trusted partner for plasmid manufacturing.

With immense pleasure, we announce VGXI's strategic partnership with Sutro Biopharma, Inc. This collaboration will support the clinical production of luveltamab tazevibulin, an innovative Folate Receptor-α (FRα)-targeting antibody-drug conjugate (ADC), which has the potential to meet the unmet needs in various FRα-expressing cancers. To learn more, click here: https://lnkd.in/g6CGWK5B

Join VGXI at BIO2024. Meet us at Booth #4947 to discover #VGXI cutting-edge pDNA solutions or connect with the team. Find us on the BIO One-on-One Partnering app, or click here to schedule a meeting: https://lnkd.in/gqbVuyPh #BIO2024 #plasmidDNA #plasmidpurification    Jeff Whitmore Justin Smith Christy Franco, Ph.D. Michelle Stretz Rebecca Bronikowski

VGXI will be attending the International Society for Cell and Gene Therapy conference in Vancouver! We look forward to seeing everyone there.    #ISCT2024 #cellandgenetherapy #plamsidpurification #USBasedCDMO

Just Released: VGXI’s Pre-Clinical Plasmid Production Flyer! Click the link below to access a comprehensive resource of pre-clinical plasmid DNA manufacturing solutions. Access here: https://lnkd.in/dphGjwnt